[go: up one dir, main page]

NO980649D0 - Biokonjugater av mangankoplekser og anvendelse derav som katalysatorer - Google Patents

Biokonjugater av mangankoplekser og anvendelse derav som katalysatorer

Info

Publication number
NO980649D0
NO980649D0 NO980649A NO980649A NO980649D0 NO 980649 D0 NO980649 D0 NO 980649D0 NO 980649 A NO980649 A NO 980649A NO 980649 A NO980649 A NO 980649A NO 980649 D0 NO980649 D0 NO 980649D0
Authority
NO
Norway
Prior art keywords
bioconjugates
catalysts
manganese complexes
complexes
manganese
Prior art date
Application number
NO980649A
Other languages
English (en)
Other versions
NO980649L (no
Inventor
William L Neumann
Dennis P Riley
Randy H Weiss
Susan L Henke
Patrick J Lennon
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of NO980649D0 publication Critical patent/NO980649D0/no
Publication of NO980649L publication Critical patent/NO980649L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D259/00—Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
NO980649A 1995-08-17 1998-02-16 Biokonjugater av mangankoplekser og anvendelse derav som katalysatorer NO980649L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US242195P 1995-08-17 1995-08-17
PCT/US1996/012767 WO1997006824A2 (en) 1995-08-17 1996-08-14 Bioconjugates of manganese complexes and their application as catalysts

Publications (2)

Publication Number Publication Date
NO980649D0 true NO980649D0 (no) 1998-02-16
NO980649L NO980649L (no) 1998-04-02

Family

ID=21700675

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980649A NO980649L (no) 1995-08-17 1998-02-16 Biokonjugater av mangankoplekser og anvendelse derav som katalysatorer

Country Status (12)

Country Link
EP (1) EP0844886A2 (no)
JP (1) JP2000513322A (no)
KR (1) KR19990037647A (no)
CN (1) CN1200039A (no)
AU (1) AU700958B2 (no)
BR (1) BR9610347A (no)
CA (1) CA2229799A1 (no)
CZ (1) CZ39898A3 (no)
IL (1) IL123040A0 (no)
NO (1) NO980649L (no)
PL (1) PL324993A1 (no)
WO (1) WO1997006824A2 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL144503A0 (en) 1999-01-25 2002-05-23 Nat Jewish Med & Res Center Substituted porphyrins
CA2394959A1 (en) 1999-12-23 2001-07-05 Amersham Plc Labelled ascorbic acid derivatives
US20050176790A1 (en) 2001-02-28 2005-08-11 Johannes Bartholomaus Pharmaceutical salts
EP1439842A4 (en) 2001-06-01 2009-09-02 Nat Jewish Med & Res Center OXIDANT CAPTAIN FOR THE TREATMENT OF DIABETES OR FOR THE USE IN THE TRANSPLANTATION OR INDUCTION OF IMMUNOTOLERANE
CN102088991A (zh) 2008-05-13 2011-06-08 堪萨斯大学 金属提取肽标签和相关方法
ES2464728T3 (es) 2008-05-23 2014-06-03 National Jewish Health Compuestos para su uso en el tratamiento de lesiones asociadas con la exposición a una especie química alquilante
CA2849456C (en) * 2011-09-26 2021-12-07 Galera Therapeutics, Llc Methods for treatment of diseases
WO2013181461A2 (en) 2012-06-01 2013-12-05 University Of Kansas Metal abstraction peptide with superoxide dismutase activity
CN110520107A (zh) * 2017-02-15 2019-11-29 加莱拉实验室有限责任公司 用于局部肠递送的五氮杂大环状环配合物
CN108752383B (zh) * 2018-05-02 2020-10-30 江苏理工学院 一种具有sod活性的吡唑羧酸酯锰配合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880832A (en) * 1987-03-06 1989-11-14 Sumitomo Pharmaceuticals Company, Ltd. Liposoluble platinum (II) complex and preparation thereof
DE69224839T2 (de) * 1991-07-19 1998-10-08 Monsanto Co Mangan-Komplexe mit Stickstoff enthaltenden makrozyklischen Liganden, wirksam als Superoxiddismutasekatalysatoren.
US6204259B1 (en) * 1993-01-14 2001-03-20 Monsanto Company Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
WO1995028968A1 (en) * 1994-04-22 1995-11-02 Monsanto Company Diagnostic image analysis with metal complexes
US6525041B1 (en) * 1995-06-06 2003-02-25 Pharmacia Corporation Manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
EP0830351A1 (en) * 1995-06-07 1998-03-25 Monsanto Company Process for preparing substituted polyazamacrocycles

Also Published As

Publication number Publication date
CN1200039A (zh) 1998-11-25
EP0844886A2 (en) 1998-06-03
KR19990037647A (ko) 1999-05-25
WO1997006824A3 (en) 1997-07-03
NO980649L (no) 1998-04-02
JP2000513322A (ja) 2000-10-10
PL324993A1 (en) 1998-07-06
MX9801322A (es) 1998-05-31
BR9610347A (pt) 1999-06-01
CA2229799A1 (en) 1997-02-27
AU6765596A (en) 1997-03-12
CZ39898A3 (cs) 1998-07-15
AU700958B2 (en) 1999-01-14
WO1997006824A2 (en) 1997-02-27
IL123040A0 (en) 1998-09-24

Similar Documents

Publication Publication Date Title
ATE285767T1 (de) Kombinationstherapie, enthaltend atorvastatin und bluddrucksenkendes mittel
NO307925B1 (no) Bicykliske aromatiske forbindelser, anvendelse derav, og farmasøytiske og kosmetiske preparater
DE69620871D1 (de) Geträgerter katalysatoraktivator
FI964874A (fi) Vihannesten käsittely
DE69712278D1 (de) Verdicktes Körperpflegemittel
DK0840595T3 (da) Solbeskyttelsesmiddel
DK0820459T3 (da) Organoboran-polyoxyalkylenpolyamin-komplekser og adhæsivsammensætninger fremstillet dermed
DE69519372D1 (de) Hautreinigungsmittel
ATE246485T1 (de) Hautreinigungsmittel
DE69305615D1 (de) Parfümiertes mittel
DE69417381D1 (de) Zahnpflegemittel
DE69602787D1 (de) Rotationsbremse und ihre Verwendung
DE59608723D1 (de) Polycyclische Iminooxadiazindione, deren Herstellung und Verwendung
DE69520235D1 (de) Schweisshemmende mittel
NO965102D0 (no) Bicykliske aromatiske forbindelser, anvendelser derav, og farmasöytiske og kosmetiske preparater
DE69638041D1 (de) Nichtselektiver Oxidationskatalysator und seine Verwendungen
DE59609662D1 (de) Haarbehandlungsmittel
NO980649D0 (no) Biokonjugater av mangankoplekser og anvendelse derav som katalysatorer
DK0643922T3 (da) Aromatiserende middel
NO974400D0 (no) Kombinasjonspreparater inneholdende benazepril eller benazeprilat og valsartan
DE69502704D1 (de) Hautreinigungsmittel
DE69614692D1 (de) Leistungsangetriebenes selbstprüfungsverfahren
NO996322D0 (no) Zwitterionisk katalysatoraktivator
FI950389A0 (fi) Ny medicinsk anvaendning av hemiprodukter
DE69603226D1 (de) Jodkomplex und dessen Verwendung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application